Neuland Pharma Research Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 261.90 Cr
- Revenue Growth 23.87%
- Profit Growth 169.49%
- Ebitda 220.62%
- Net Worth 62.63%
- Total Assets 29.45%
About Neuland Pharma Research
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100TG2012PTC080474
- Company No.
080474
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2012
- Date of AGM
28 Dec 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Neuland Pharma Research Private Limited offer?
Neuland Pharma Research Private Limited offers a wide range of products and services, including Project Management, IT Infrastructure Solution, Business Consultant, Facility Management Services, Web Development & Marketing Services, Website Development Services, Content Writing Service, Research Development Services, Legal Drafting & Litigation Services, Dispute Resolution Service.
Who are the key members and board of directors at Neuland Pharma Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saharsh Davuluri  | Director | 23-Apr-2012 | Current |
| Sucheth Davuluri | Director | 23-Apr-2012 | Current |
| Ramamohan Rao | Director | 23-Apr-2012 | Current |
Financial Performance of Neuland Pharma Research.
Neuland Pharma Research Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 23.87% increase. The company also saw a substantial improvement in profitability, with a 169.49% increase in profit. The company's net worth Soared by an impressive increase of 62.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neuland Pharma Research?
In 2017, Neuland Pharma Research had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neuland Laboratories Ltd.Sucheth Davuluri, Saharsh Davuluri and 1 more are mutual person
Ypo South Asia ChapterSucheth Davuluri is a mutual person
Asvi Therapeutics Private LimitedSucheth Davuluri, Saharsh Davuluri and 1 more are mutual person
- Pattancheru Enviro-Tech Limited
Ramamohan Rao is a mutual person
Charges (Loans)
₹0
₹261.90 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 150.90 Cr
- Export-Import Bank Of India : 76.00 Cr
- Bank Of India : 20.00 Cr
- Sbi Global Factors Limited : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2014 | Bank Of India | ₹20.00 Cr | Satisfied |
| 08 Aug 2013 | Export-Import Bank Of India | ₹10.00 Cr | Satisfied |
| 08 Aug 2013 | Export-Import Bank Of India | ₹36.00 Cr | Satisfied |
| 08 Aug 2013 | Export-Import Bank Of India | ₹30.00 Cr | Satisfied |
| 08 Aug 2013 | Sbi Global Factors Limited | ₹15.00 Cr | Satisfied |
How Many Employees Work at Neuland Pharma Research?
Unlock and access historical data on people associated with Neuland Pharma Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neuland Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuland Pharma Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
